AG Healey is using the office’s authority to take on the business practices by pharmaceutical manufacturers and wholesalers that have fueled the opioid epidemic in Massachusetts. In June 2017, AG Healey together with about 40 of her fellow state AGs – rural and urban – Democrat and Republican – launched an investigation into branded opioid manufacturers and distributors companies, to determine if their sales, marketing, and distribution practices contributed to this crisis.
What we’re asking these companies is: What did they know? And when?
Did they communicate how addictive these drugs were when they sold them?
Did they track and report suspicious orders?
Did they ignore information that could have saved lives?
Our pharmaceutical investigation includes manufacturers Purdue Pharma, Endo, Janssen, Teva, and Allergan; and the distribution wholesalers AmerisourceBergen, Cardinal Health, and McKesson. As the investigation advances, these companies are producing documents, and we are deposing witnesses. All Americans need to know what happened to our families and our communities. Throughout the investigation, the bipartisan leadership team has made it clear that any resolution will require a transformation of this industry – the kind that changes the course of this epidemic.